Journal
Annals of Clinical and Translational Neurology
Publication Date
11-1-2022
Volume
9
Issue
11
First Page
1739
Last Page
1751
Document Type
Open Access Publication
DOI
10.1002/acn3.51670
Rights and Permissions
Aschenbrenner, A.J., Li, Y., Henson, R.L., Volluz, K., Hassenstab, J., Verghese, P., West, T., Meyer, M.R., Kirmess, K.M., Fagan, A.M., Xiong, C., Holtzman, D., Morris, J.C., Bateman, R.J. and Schindler, S.E. (2022), Comparison of plasma and CSF biomarkers in predicting cognitive decline. Ann Clin Transl Neurol, 9: 1739-1751. https://doi.org/10.1002/acn3.51670 © 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Recommended Citation
Aschenbrenner, Andrew J; Li, Yan; Henson, Rachel L; Volluz, Katherine; Hassenstab, Jason; Verghese, Philip; West, Tim; Meyer, Matthew R; Kirmess, Kristopher M; Fagan, Anne M; Xiong, Chengjie; Holtzman, David; Morris, John C; Bateman, Randall J; and Schindler, Suzanne E, "Comparison of plasma and CSF biomarkers in predicting cognitive decline." Annals of Clinical and Translational Neurology. 9, 11. 1739 - 1751. (2022).
https://digitalcommons.wustl.edu/oa_4/1808
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
